Study on the Application of Liquid Chromatography-Tandem Mass Spectrometry for the Determination of Aldosterone and Renin Activity in the Diagnosis of Primary Aldosteronism by Captopril Test

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorPeking Union Medical College Hospital

About this trial

Primary aldosteronism (PA) is the most common cause of secondary hypertension. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is more accurate than the traditional radioimmunoassay method in measuring aldosterone. This study aims to establish a more precise diagnostic cutoff value for the captopril stimulation test (CCT) by measuring aldosterone levels using LC-MS/MS. The investigators will combine the detection results of CCT from healthy volunteers and suspected PA patients, etc., to determine the new CCT cutoff value. The investigators expect to improve the diagnostic accuracy of PA, helping clinicians identify this curable cause of hypertension earlier and more accurately, and achieving precise treatment.

Eligibility criteria

Qualifiers

Age 18-70 years old

BMI: 18.5-23.9kg/m²

Gender not restricted

Blood pressure: 100-120/60-80mmHg

Disqualifiers

Those with a family history of hypertension or with clinical manifestations of secondary hypertension

Those who have been taking drugs that may affect the RAAS system for a long time (such as contraceptives, steroids, etc.)

Those with cardiac dysfunction or severe arrhythmia and unable to tolerate the test

Patients with suspected primary aldosteronism in the outpatient setting

Trial design

Treatments tested in this trial

  • Captopril inhibition test(CCT)

Treatment groups

800 Participants
are divided into 2 treatment groups